Decoding 6 Analyst Evaluations For Recursion Pharmaceuticals
Decoding 6 Analyst Evaluations For Recursion Pharmaceuticals
解析6个分析师对于Recursion Pharmaceuticals的评估
The...6 analysts have expressed a variety of opinions on Recursion Pharmaceuticals (NASDAQ:RXRX) over the past quarter, offering a diverse set of opinions from bullish to bearish.
过去一个季度，有6位分析师对Recursion Pharmaceuticals (NASDAQ:RXRX)发表了各种不同的意见，从看好到看淡不一而足。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级概况，突出了过去30天内情绪的变化，并将其与之前的月份进行了比较。
Analysts have recently evaluated Recursion Pharmaceuticals and provided 12-month price targets. The average target is $11.67, accompanied by a high estimate of $17.00 and a low estimate of $6.00. A decline of 15.62% from the prior average price target is evident in the current average.
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
The...
净...
登录免费看全文
登录/注册
资讯热榜
更新时间